Ultralife Co. (NASDAQ:ULBI - Get Free Report) Director Bradford T. Whitmore bought 11,980 shares of the firm's stock in a transaction on Friday, May 23rd. The shares were acquired at an average cost of $5.41 per share, with a total value of $64,811.80. Following the purchase, the director now directly owns 1,060,067 shares of the company's stock, valued at approximately $5,734,962.47. This represents a 1.14% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Ultralife Stock Up 0.5%
Shares of NASDAQ ULBI traded up $0.03 during midday trading on Friday, hitting $6.69. The stock had a trading volume of 113,381 shares, compared to its average volume of 70,568. The business's 50 day moving average is $5.00 and its 200-day moving average is $6.42. Ultralife Co. has a 52 week low of $4.07 and a 52 week high of $12.40. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The company has a market cap of $111.27 million, a P/E ratio of 12.16 and a beta of 0.77.
Ultralife (NASDAQ:ULBI - Get Free Report) last released its quarterly earnings data on Friday, May 9th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.02). Ultralife had a net margin of 5.44% and a return on equity of 7.92%. The business had revenue of $50.75 million during the quarter, compared to the consensus estimate of $54.50 million. During the same period last year, the company posted $0.21 earnings per share.
Institutional Investors Weigh In On Ultralife
Several institutional investors have recently modified their holdings of the business. IFP Advisors Inc lifted its stake in Ultralife by 24.6% during the 1st quarter. IFP Advisors Inc now owns 14,200 shares of the technology company's stock valued at $76,000 after acquiring an additional 2,800 shares during the period. Jones Financial Companies Lllp raised its holdings in shares of Ultralife by 1,428.7% during the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company's stock valued at $82,000 after purchasing an additional 14,287 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Ultralife by 30.7% during the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company's stock valued at $90,000 after purchasing an additional 2,836 shares during the last quarter. Barclays PLC lifted its position in Ultralife by 13.7% during the fourth quarter. Barclays PLC now owns 15,233 shares of the technology company's stock valued at $113,000 after purchasing an additional 1,838 shares during the period. Finally, Pitti Group Wealth Management LLC boosted its holdings in Ultralife by 23.4% in the first quarter. Pitti Group Wealth Management LLC now owns 21,120 shares of the technology company's stock worth $114,000 after purchasing an additional 4,000 shares during the last quarter. 30.68% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, Wall Street Zen raised Ultralife from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.
Get Our Latest Research Report on ULBI
Ultralife Company Profile
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Recommended Stories

Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.